Sophoridine is a New Antitumor Medicine with New Molecular Structure

LI Xue-mei,WU Yun-guang,PAN Da-xin,WU Lian-kui,YU Yue-hua,ZHANG Ai-hua,CHEN Shao-li,GUAN Zhong-zhen,YANG Xiu-yu
DOI: https://doi.org/10.3321/j.issn:1003-3734.2006.08.024
2006-01-01
Abstract:Sophoridine extracted from the Sophora alopecuroides with the purity of 99. 5% take effect of antitumor in those mice bearing Lewis Lung Carcinoma (LLC) ,S180,U14 and ECA etc, the rates of inhibition between 30 -60% in vivo. It can kill the cancer cell directly and disturb the G1 stage and G2 stage of the proliferation cycle. It also has influence on apoptosis and can inhibit the activities of TOPO I enzyme. Sophoridine is well absorpted quickly and distributed, excreted unchanged by glomerular filtration. It exhibits kinetic patterns that is consistent with two compartment model. The notable effect of Sophoridine in human gestational trophoblastic disease (GTD) , and moderate effect of it in lymphosorcoma and gastrointestinal tumor were approved by clinical research from the hospitals. Enough evidence showed that Sophoridine is lower in toxicity and no marked effect on main organs and born marrow of rats and patient were noticed. Beside, hematogenic function of born marrow work properly. The side effect mainly involves the nervous system.
What problem does this paper attempt to address?